← Evidence map

ArticleTherapeutic innovation & regulatory science2026

Comparison of Labeled Dosages Between Japan and the United States for Drugs Approved in Japan from 2020 to 2025.

Takashi Funatogawa et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 42902124